SCHEMBL13487474

SCHEMBL13487474

Cc1ccc2c(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)c3ccccc3c(-c3ccc4c(c3)-c3ccccc3C4(C)C)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 7/20 0.39
ALDH1A1 P00352 7/20 0.39
MAPT P10636 6/20 0.39
NPSR1 Q6W5P4 3/20 0.39
LMNA P02545 2/20 0.39
RECQL P46063 1/20 0.39
HPGD P15428 5/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSP90AA1 P07900 1/20 0.39
PDK2 Q15119 3/20 0.37
AGTR1 P30556 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PPARG P37231 2/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487844 0.94 MEN1 (0.40) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487544 0.91 PDK2 (0.38) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487476 0.90 ALDH1A1 (0.39) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487781 0.90 PDK2 (0.37) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487681 0.87 CTRC (0.37) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487632 0.87 ENPP1 (0.36) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487477 0.87 MEN1 (0.35) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487077 0.87 KDM4E (0.39) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13487462 0.86 NQO2 (0.37) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13488159 0.86 PDK2 (0.39) MEN1KMT2AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 MEN1 3017/4885KMT2A 3530/4885KDM4E 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.